Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 181 Lymphoma 97 Lymphoma, Large B-Cell, Diffuse 96 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Sarcoma 69 Hodgkin Disease 54 Lymphoma, Non-Hodgkin 41 Triple Negative Breast Neoplasms 37 Burkitt Lymphoma 36 Lymphoma, Mantle-Cell 32 Leukemia 32 Lymphoma, Follicular 30 Multiple Myeloma 28 Carcinoma, Hepatocellular 28 Neoplasm Metastasis 23 Ovarian Neoplasms 21 Neoplasms 21 Lymphoma, Large-Cell, Anaplastic 18 Osteosarcoma 17 Lymphoma, B-Cell 17 Prostatic Neoplasms 16 Neuroblastoma 15 Lymphoma, T-Cell, Peripheral 15 Urinary Bladder Neoplasms 14 Recurrence 13 Lymphoma, Large-Cell, Immunoblastic 13 Inflammatory Breast Neoplasms 13 Immunoblastic Lymphadenopathy 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Stomach Neoplasms 10

Interventions

Radiotherapy 1 Paclitaxel 1 Olanzapine 1 Megestrol Acetate 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prosthesis Failure × Doxorubicin × Clear all

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡